Arcturus Therapeutics Holdings Inc.
ARCT
$8.25
-$0.39-4.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.27% | -116.23% | -46.49% | 34.78% | 53.09% |
| Total Depreciation and Amortization | -3.52% | -10.62% | -2.05% | -2.75% | -2.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.10% | 48.79% | -6.78% | -5.31% | -24.15% |
| Change in Net Operating Assets | -24.17% | 132.74% | -181.50% | 87.10% | -242.08% |
| Cash from Operations | -19.81% | 5.39% | -198.02% | 83.62% | -12,272.54% |
| Capital Expenditure | -- | 148.62% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -61.36% | 148.62% | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -99.86% | 854.12% | 347.08% | 40.51% | 45.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.86% | 854.12% | 108.32% | -196.91% | 11,239.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -335.65% | 72.37% | 21.36% | -2.00% | -13,286.67% |